Avancerad sökning
Visar resultat 1 - 5 av 55 uppsatser som matchar ovanstående sökkriterier.
1. Serum TK1 activity and SAA concentration as biomarkers to differentiate lymphoma from gastrointestinal disease in cats
Master-uppsats, SLU/Dept. of Clinical SciencesSammanfattning : Alimentary lymphoma is one of the most common malignant neoplasms in the gastrointestinal (GI) tract in cats. Since the clinical signs often are identical to those of inflammatory bowel disease (IBD), and the findings on diagnostic imaging and endoscopic mucosal biopsies overlap, invasive biopsy sampling from the GI tract is needed to be able to differentiate these two diseases from each other. LÄS MER
2. TransRUnet: 2D Detection and Segmentation of Lymphoma Lesions in Full-Body PET-CT Images
Master-uppsats, KTH/Medicinteknik och hälsosystemSammanfattning : Identification and localization of FDG-avid lymphoma lesions in PET-CT image volumes is of high importance for the diagnosis and monitoring of treatment progress in lymphoma patients. This process is tedious, time-consuming, and error-prone, due to large image volumes and the heterogeneity of lesions. LÄS MER
3. " Optimization of Margins and Plan Robustness for Proton Therapy of Hodgkin’s Lymphoma"
Master-uppsats, Lunds universitet/SjukhusfysikerutbildningenSammanfattning : Purpose/Background: Utilizing proton therapy (PT) for treatment of Hodgkin’s lymphoma (HL) has demonstrated favorable features, particularly a reduced dose to organs at risk (OAR) in comparison with photon radiotherapy. However, there is a coherent complexity with PT including its uncertainties, such as range-uncertainties and set-up variations as protons are highly sensitive to tissue density variations within the beam-path. LÄS MER
4. An Application of Cluster Analysis in Identifying and Evaluating Prognostic Subgroups for Therapy-Related Acute Myeloid Leukemia
Master-uppsats, Uppsala universitet/Statistiska institutionenSammanfattning : Treatment for lymphoma with alkylating therapy is known to increase the risk of secondary malignancies such as Acute Myeloid Leukemia (AML), although the risk is not fully understood. This study investigates the characteristics of AML that arise after lymphoma treatment in contrastto AML cases without a prior lymphoma. LÄS MER
5. Improving antibody-based immunotherapy protocols in vitro : Study on optimization of antitumor immunity by antibody-dependent phagocytosis with the monoclonal antibody rituximab
Master-uppsats, Uppsala universitet/Institutionen för biologisk grundutbildningSammanfattning : The monoclonal antibody Rituximab (RTX) has been widely and successfully used to treat non-Burkitt B cell lymphoma in human patients. The combination of immunotherapy with low-dose chemotherapy has increased the success of the treatment and translated into increased patients’ survival. LÄS MER